Masimo Corporation (MASI)
179.65
-1.66 (-0.92%)
At close: Feb 18, 2025, 3:59 PM
180.36
0.40%
After-hours: Feb 18, 2025, 04:00 PM EST
undefined% (undefined)
| Bid | 176.96 |
| Market Cap | 9.62B |
| Revenue (ttm) | - |
| Net Income (ttm) | - |
| EPS (ttm) | 1.45 |
| PE Ratio (ttm) | 123.9 |
| Forward PE | n/a |
| Analyst | Buy |
| Ask | 183.89 |
| Volume | 294,771 |
| Avg. Volume (20D) | 471,291 |
| Open | 178.81 |
| Previous Close | 181.31 |
| Day's Range | 178.05 - 181.50 |
| 52-Week Range | 101.61 - 183.14 |
| Beta | undefined |
About MASI
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products t...
Industry Medical - Instruments & Supplies
Sector Healthcare
IPO Date Aug 8, 2007
Employees 3,800
Stock Exchange NASDAQ
Ticker Symbol MASI
Website https://www.masimo.com
Analyst Forecast
According to 6 analyst ratings, the average rating for MASI stock is "Buy." The 12-month stock price forecast is $193, which is an increase of 7.43% from the latest price.
Buy 83.33%
Hold 16.67%
Sell 0.00%
Next Earnings Release
Masimo Corporation is scheduled to release its earnings on Feb 25, 2025,
after market closes.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
4 months ago
+6.02%
Masimo Corp shares are trading higher after the co...
Unlock content with
Pro Subscription
6 months ago
+11.29%
Masimo shares are trading higher after the company reported better-than-expected Q2 financial results and issued Q3 revenue guidance above estimates. Also, Piper Sandler maintained an Overweight rating on the stock and raised its price target from $160 to $165.
